- Record: found
- Abstract: not found
- Article: not found
LBA4 Association of KRAS mutational status with response to pembrolizumab monotherapy given as first-line therapy for PD-L1-positive advanced non-squamous NSCLC in Keynote-042
R.S. Herbst ,
G. Lopes ,
D.M. Kowalski ,
K. Kasahara ,
Y.-L. Wu ,
G. De Castro ,
B.C. Cho ,
H.Z. Turna ,
R. Cristescu ,
D. Aurora-Garg ,
J. Lunceford ,
J. Kobie ,
M. Ayers ,
M.C. Pietanza ,
B. Piperdi ,
T.S.K. Mok
December 2019
December 2019
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.